Ferozsons Laboratories (KAR:FEROZ) Other Current Payables: ₨186 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
72 GF Score
Price ₨376.57
GF Value ₨426.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ferozsons Laboratories Other Current Payables?

Ferozsons Laboratories KAR:FEROZ +0.39% 72 Other Current Payables is ₨186 Mil as of Mar. 2026. GuruFocus rates KAR:FEROZ with a GF Score™ of 72/100 and a GF Value™ of ₨426.62 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Ferozsons Laboratories's Other Current Payables for the quarter that ended in Mar. 2026 was ₨186 Mil.

Ferozsons Laboratories's quarterly Other Current Payables declined from Sep. 2025 (₨183 Mil) to Dec. 2025 (₨180 Mil) but then increased from Dec. 2025 (₨180 Mil) to Mar. 2026 (₨186 Mil).

Ferozsons Laboratories's annual Other Current Payables increased from Jun. 2023 (₨323 Mil) to Jun. 2024 (₨598 Mil) but then declined from Jun. 2024 (₨598 Mil) to Jun. 2025 (₨493 Mil).

Ferozsons Laboratories Other Current Payables Related Terms

Ferozsons Laboratories Other Current Payables Historical Data

* Premium members only.

The historical data trend for Ferozsons Laboratories's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories Other Current Payables Chart

Ferozsons Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 217.14 228.75 322.65 597.61 493.42

Ferozsons Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.13 493.42 182.99 179.64 186.26
KAR:FEROZ
72GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ferozsons Laboratories Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₨186 Mil mean?
Ferozsons Laboratories (KAR:FEROZ) has a Other Current Payables of ₨186 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Ferozsons Laboratories and its competitors.
Is Ferozsons Laboratories' Other Current Payables too high?
Ferozsons Laboratories' current Other Current Payables is ₨186 Mil. Overall, Ferozsons Laboratories has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Other Current Payables compare to ZTS and UTHR?
Ferozsons Laboratories' Other Current Payables of ₨186 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Ferozsons Laboratories and its competitors. Ferozsons Laboratories's current Other Current Payables is ₨186 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Modestly Undervalued. The stock's GF Value™ is ₨426.62, compared to a current price of ₨376.57 — trading 11.7% below its estimated fair value. The current Other Current Payables is ₨186 Mil. Ferozsons Laboratories' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Other Current Payables is ₨186 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨376.57 is trading 11.7% below its estimated GF Value™ of ₨426.62. GuruFocus considers Ferozsons Laboratories to be Modestly Undervalued.

Key valuation signals for KAR:FEROZ:

  • Other Current Payables: ₨186 Mil
  • GF Value™: ₨426.62 vs. price of ₨376.57 (11.7% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
72GF Score

Get the complete analysis for KAR:FEROZ

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨376.57
Price
₨426.62
GF Value